Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Department of Radiation Oncology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, China.
Sci Rep. 2024 Aug 2;14(1):17887. doi: 10.1038/s41598-024-68676-1.
Re-irradiation with intensity-modulated radiotherapy (IMRT) remains the primary treatment modality for inoperable locally recurrent nasopharyngeal carcinoma (NPC). However, the rate of radiation-related late adverse effects is often substantially high. Therefore, we aimed to explore failure patterns and individualized treatment plans of re-irradiation for inoperable locally recurrent NPC. Ninety-seven patients who underwent IMRT were retrospectively analyzed. Sixty-two patients had clinical target volume of recurrence (rCTV) delineated, and thirty-five patients had only gross tumor volume of recurrence (rGTV) delineated. Twenty-nine patients developed second local failures after re-irradiation with IMRT (28 cases available). Among those patients, 64.3% (18/28) of patients and 35.7% (10/28) developed in-field or out-field, respectively. No statistical correlation was observed between target volume (rGTV or rCTV) and the local recurrence rate, local failure patterns, grade ≥ 3 toxicity, and survival. Multivariate analysis showed that recurrent T (rT) stage (HR 2.62, P = 0.019) and rGTV volume (HR 1.73, P = 0.037) were independent prognostic factors for overall survival (OS). Risk stratification based on rT stage and rGTV volume revealed that low risk group had a longer 3-year OS rate (66.7% vs. 23.4%), lower total grade ≥ 3 toxicity (P = 0.004), and lower re-radiation associated mortality rates (HR 0.45, P = 0.03) than high risk group. This study demonstrates that the delineation of rCTV may not be beneficial for re-irradiation using IMRT in locally recurrent NPC. Patients with low risk were most suitable for re-irradiation, with maximizing local salvage and minimizing radiation-related toxicities. More precise and individualized plans of re-irradiation are warranted.
对于不能手术的局部复发性鼻咽癌(NPC),再放疗仍然是主要的治疗方式。然而,放射相关的晚期不良反应发生率往往很高。因此,我们旨在探讨不可手术的局部复发性 NPC 再放疗的失败模式和个体化治疗计划。对 97 例接受调强放疗(IMRT)的患者进行回顾性分析。62 例患者有临床靶区复发(rCTV)勾画,35 例患者只有肿瘤复发(rGTV)勾画。29 例患者在接受 IMRT 再放疗后发生第二次局部复发(28 例可评估)。在这些患者中,64.3%(18/28)的患者和 35.7%(10/28)的患者发生了场内或场外复发。未观察到靶区(rGTV 或 rCTV)与局部复发率、局部失败模式、≥3 级毒性和生存之间存在统计学相关性。多因素分析显示,复发性 T 期(rT)(HR 2.62,P=0.019)和 rGTV 体积(HR 1.73,P=0.037)是总生存(OS)的独立预后因素。基于 rT 期和 rGTV 体积的风险分层显示,低危组的 3 年 OS 率更高(66.7%比 23.4%),总≥3 级毒性发生率更低(P=0.004),再放疗相关死亡率也更低(HR 0.45,P=0.03)。本研究表明,在局部复发性 NPC 中,使用 IMRT 进行再放疗时,rCTV 的勾画可能无益。低危患者最适合再放疗,可最大限度地提高局部挽救率,最小化放射相关毒性。需要更精确和个体化的再放疗计划。